Spero Therapeutics Shareholders Equity (Quarterly) Trends

Spero Therapeutics Inc (SPRO)

1.42 -0.02 (-1.05%) USD | NASDAQ | Apr 24, 16:00

1.42 0.00 (0.00%) After-Hours: 20:00

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	106.89M
September 30, 2023	53.70M
June 30, 2023	54.78M
March 31, 2023	64.84M
December 31, 2022	75.93M
September 30, 2022	32.48M
June 30, 2022	35.92M
March 31, 2022	62.47M
December 31, 2021	88.29M
September 30, 2021	111.90M
June 30, 2021	90.25M
March 31, 2021	118.85M
December 31, 2020	132.04M
September 30, 2020	132.79M

Date	Value
June 30, 2020	73.71M
March 31, 2020	82.43M
December 31, 2019	74.57M
September 30, 2019	92.68M
June 30, 2019	109.31M
March 31, 2019	112.97M
December 31, 2018	115.50M
September 30, 2018	125.20M
June 30, 2018	65.31M
March 31, 2018	74.54M
December 31, 2017	84.60M
September 30, 2017	23.92M
June 30, 2017	31.78M
December 31, 2016	10.17M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

32.48M

Minimum

Sep 2022

132.79M

Maximum

Sep 2020

83.89M

Average

82.43M

Median

Mar 2020

Shareholders Equity (Quarterly) Benchmarks

Retractable Technologies Inc	99.29M
OptiNose Inc	-86.61M
scPharmaceuticals Inc	37.22M
electroCore Inc	7.442M
Equillium Inc	22.57M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	182.39M
Total Liabilities (Quarterly)	75.50M
Current Ratio	3.532